BioNTech Taps Guido Oelkers as CEO, Succeeding Ugur Sahin
BNTX is trading near its 52-week low of $79.52 (15% above the low).
Summary
BioNTech appoints Guido Oelkers as CEO, replacing co-founder Ugur Sahin, who will leave to start a new company with co-founder Özlem Türeci. The leadership change comes amid a major restructuring and pipeline transition.
Key Events · Executive and Board Changes · BNTX
-
New CEO Appointed
Guido Oelkers, currently CEO of Sobi, has been appointed as BioNTech's new CEO and will take office by February 1, 2027, succeeding co-founder Ugur Sahin.
-
Founder Departures
Both Ugur Sahin and Özlem Türeci will leave BioNTech to lead a new independent company, while a search for a new Chief Medical Officer is underway.
-
Leadership Transition Amid Restructuring
The CEO change follows a 25% workforce reduction and a $1 billion share buyback program announced in May 2026, as BioNTech pivots toward its oncology pipeline.
-
Strategic Continuity Questions
Oelkers aims to make BioNTech a multi-product company by 2030, but the departure of both scientific founders introduces uncertainty around pipeline execution and corporate strategy.
Analysis · BNTX · Life Sciences
BioNTech has appointed Guido Oelkers, currently CEO of Sobi, as its new chief executive, with a start date no later than February 1, 2027. He replaces co-founder Ugur Sahin, who will depart to lead a new independent company alongside co-founder Özlem Türeci. This marks a major leadership transition for a company already in the midst of significant restructuring, including a 25% workforce reduction and a $1 billion buyback. Oelkers brings a track record of scaling biopharma companies, but the departure of both founders raises questions about strategic continuity and the future of the pipeline.
At the time of this filing, BNTX was trading at $91.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.9B. The 52-week trading range was $79.52 to $124.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.